Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02713334 · ClinicalTrials.gov registry record
Cancer Patients Decision Making and Family Communication About Secondary Findings From Tumor Genomic Profiling
A clinical trial of Tumor Genomic Profiling, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 495
- Enrollment target
- 1
- Study location
NCT02713334 is a study of Tumor Genomic Profiling that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 495 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02713334, a study of Tumor Genomic Profiling, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 495 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this protocol is to characterize cancer patients' responses to learning their secondary findings arising from tumor genomic profiling, and the process and outcomes of their decisions to communicate these results to their families.
Conditions Studied
Interventions
- BEHAVIORAL survey
- BEHAVIORAL semi-structured interview
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 495 participants |
| Start Date | 2016-02-25 |
| Est. Completion | 2026-02-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02713334
The ClinicalTrials.gov registry entry for NCT02713334 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 495 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tumor Genomic Profiling appearing as the primary indexed condition, and to 2 interventions - of which survey is the first listed.
NCT02713334 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02713334 about?
NCT02713334 is a clinical study titled "Cancer Patients Decision Making and Family Communication About Secondary Findings From Tumor Genomic Profiling". The objective of this protocol is to characterize cancer patients' responses to learning their secondary findings arising from tumor genomic profiling, and the process and outcomes of their decisions to communicate these results to their families.
What is the current status of trial NCT02713334?
This trial is currently active not recruiting. The enrollment target is 495 participants. The study started on 2016-02-25. Estimated completion is 2026-02-25.
What conditions does trial NCT02713334 study?
This clinical trial studies the following conditions: Tumor Genomic Profiling.
What interventions are being tested in trial NCT02713334?
The interventions under investigation include: survey (BEHAVIORAL), semi-structured interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT02713334?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02713334 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.